好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Benign paroxysmal positional vertigo: The “Sémont PLUS maneuver” is more effective than the Sémont maneuver – a prospective multinational randomized single-blinded trial
Neuro-ophthalmology/Neuro-otology
S32 - Neuro-ophthalmology/Neuro-otology (5:06 PM-5:18 PM)
009
To compare the efficacy of the Sémont (“SM”) with the new “Sémont PLUS maneuver” (“SM+”) in a prospective multinational randomized single-blinded trial in patients with posterior canal benign paroxysmal positional vertigo (pc-BPPV).
Although there is Class I evidence for the efficacy of the Sémont and Epley maneuvers in pc-BPPV many patients suffer longer than necessary. Based on our biophysical model of BPPV we hypothesized that the “SM+” is more effective than the “SM” because this model showed that tilting of the affected canal towards the affected side moves the otoconia further towards the exit of the posterior canal.  

In a prospective multinational (Germany, Italy, Belgium) randomized single-blinded treatment trial patients with proven posterior canal BPPV – according to the diagnostic criteria of the International Classification of Vestibular Disorders – were randomly assigned (1:1) to the “SM” or “SM+”. The latter is characterized by an overextension of the head/body by 45° below earth horizontal line during step 2 of the maneuver. The first three maneuvers were performed by the physician. The patients were then instructed on how to do the maneuvers which they should perform 3times in the morning, 3times at noon and 3times at night.  Each morning after the first maneuver of each day the patient documents in a standardized evaluation sheet, whether vertigo occurred or not. The primary endpoint was: “How long (in days) does it take until no attacks can be induced “in the morning” by the maneuvers?”

In the 167 patients analysed it took 3.9 days (mean; range 1-33 days) for the “SM” and only 2.3 days (range 1-32 days) for the “SM+” for recovery (p=0.015, Mann-Whitney-u-test).
This prospective multinational randomized trial showed that the “SémontPLUS maneuver” is significantly more effective than the Sémont maneuver. It also confirms the hypothesis based on a biophysical model of BPPV.
Authors/Disclosures
Michael Strupp, MD, DO, FAAN (Hospital of the Ludwig Maximilians University, Munich, Dept of Neurology)
PRESENTER
Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has stock in IntraBio.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file